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Testing for the novel coronavirus disease (COVID-
19) is essential to help researchers understand the 
epidemiology of the disease and to help policymakers 
and healthcare professionals reduce spread, 
strategically deliver treatment resources, and devise 
appropriate policy responses. There is already 
evidence that U.S. states with more confirmed 
infections (which can only be determined with testing) 
are more likely than their peer states with fewer 
confirmed cases to enact physical distancing protocols, 
thereby dramatically reducing travel and other 
mechanisms for virus spread. In his March 23 media 
briefing,1 the World Health Organization (WHO) 
Director General made a strong call for the testing of 
every suspected case as part of an “aggressive and 
targeted” tactic against COVID-19. 
 
Testing Rates are Lowest in the 
Unhealthiest States 
Unfortunately, there have been substantial resource 
constraints and other challenges with conducting adequate testing. Resources (e.g., testing kits, medical 
personnel, personal protective equipment) and political will to conduct widespread testing have varied 
substantially across countries and even across states within the U.S. As of April 7, 2020, testing rates 
ranged from 308.9 per 100,000 population in Texas to 1,740.1 per 100,000 population in New York. 
To be sure, these testing data are dynamic and changing every day. However, this widespread variation in 
testing has implications for disparities in COVID-19 outcomes.  
 
Last week, we showed that testing rates were lower in states with larger percent black and poor 
populations. Based on testing data from this week, those testing disparities have largely disappeared 
thanks to drastic increases in testing in D.C., Louisiana, and Mississippi (states with large percent black 
and poor populations). Nonetheless, these early disparities in testing rates are troubling because delays in 
testing increase the risk of a surge in silent spread and severe COVID-19 cases in these states. There is 
already mounting evidence that black Americans are suffering from disproportionately high rates of 
infection and death from COVID-19. 
 
What has remained consistent over the past several weeks is that testing rates are lowest in the 
unhealthiest states. Figure 1 shows the number of coronavirus tests that have been conducted per 
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• COVID-19 testing rates are lowest in the least 
healthy states. Rates are lower in states with 
lower life expectancy, higher percentages of 
adults reporting fair/poor health, higher rates of 
obesity, and higher diabetes prevalence. 
• COVID-19 testing rates are lowest in states 
with the least health care access. Testing rates 
are lower in states with fewer primary care 
physicians per capita and in states with higher 
percentages of uninsured adults. 
• Several states with the lowest testing rates are 
among those who elected not to expand 
Medicaid under the Affordable Care Act. 
• Disparities in testing rates are troubling because 
delays in testing increase the risk of a surge in 
silent spread and severe COVID-19 cases in 
these states. 
• This epidemic not only reveals, but is also 
exacerbating, large health disparities across 
U.S. states. 
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100,000 population in the state on y-axis and four state-level health outcomes on the X-axis: life 
expectancy, percentage of adults reporting fair/poor health, percentage of obese adults, and percentage of 
adults with a diabetes diagnosis. The patterns are clear. Unhealthier states have lower testing rates. States 
with higher life expectancy have higher testing rates. Conversely, states with a larger share of residents 
reporting fair/poor health, higher rates of obesity, and higher rates of diabetes have lower testing rates. 
This is a major concern given that the populations in these unhealthier states are at the greatest risk of 
serious complications and death from coronavirus. This epidemic not only reveals, but is also 




Figure 1. Scatterplot of State-Level COVID-19 Testing Rates (tests per 100,000 population) by State-
Level (A) Life Expectancy, (B) Percentage of Adults Reporting Fair/Poor Health, (C) Percentage of 
Adults who are Obese, and (D) Percentage of Adults with a Diabetes Diagnosis 
Data Sources: Testing rates are current as of 4/08/2020 and come from the COVID Tracking Project; State-level 
health indicators come from the Robert Wood Johnson Foundation County Health Rankings; Figures: Shannon 
Monnat 
 
Testing Rates are Lowest in States with the Worst Health Care Access 
Further exacerbating these disparities is that the same states with the unhealthiest populations also have 
worse health care access. Testing rates are lower in states with lower health care access. Figure 2 shows 
the relationship between state testing rates and two measures of health care access. States with fewer 
primary care physicians per capita have lower testing rates (Fig. 2A). Particularly concerning is that states 
with fewer medical personnel are going to be the least equipped to deal with a surge in cases when they 
occur. They will not have the facilities, equipment, or medical personnel to handle the surge. This could 
dramatically increase case fatality rates in these states. States with a larger share of adults without health 
insurance also have lower testing rates (Fig. 2B).  Several of the states with the lowest testing rates (Texas, 
Georgia, Kansas, Oklahoma, and Alabama) elected not to expand Medicaid under the Affordable Care 
Act, a choice that is bound to have harmful COVID-19 related impacts on lower-income populations in 
these states. The uninsured are likely to face substantial barriers to testing for COVID-19 and are at higher 
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risk of contracting the virus because they are more likely to work in jobs that may increase their risk of 
exposure (e.g., service work and other employment that cannot be done from home). 
 
 
Figure 2. Scatterplot of State-Level COVID-19 Testing Rates (tests per 100,000 population) by State-
Level (A) Primary Care Physicians per Capita, (B) Percentage of Adults without Health Insurance 
Data Sources: Testing rates are current as of 4/08/2020 and come from the COVID Tracking Project; State-level 
health care access measures come from the Robert Wood Johnson Foundation County Health Rankings; Figures: 
Shannon Monnat 
 
Recommendations for Policy and/or Practice 
The Families First Coronavirus Response Act, with its mandate on free testing, presents an opportunity to 
mitigate current testing disparities. The CDC recommends widespread testing for symptomatic 
individuals including older adults, those who have chronic health conditions, and those who are immune-
compromised.2 Beyond that, we advocate for prevalence testing above and beyond testing only those 
with symptoms. Testing for prevalence (rather than just diagnosis) informs us about the progress and 
trajectory of the epidemic and can help government officials to better allocate resources and make 
informed decisions about the appropriate timing for lightening social distancing protocols. We implore 
national, state, and local governments to ramp up testing as part of the overall strategy to fight COVID-19. 
This is a health equity issue. We also call for better data collection and research to understand testing 
capacity and disparities in testing access and utilization. 
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